Episurf Medical (Nasdaq: EPIS B) today announces that a surgery with the knee implant Episealer® has been scheduled to take place in Poland in the coming weeks.

"We are now adding Poland to the markets where surgeries with the Episealer® implant are performed. Adding to the history, one of the first Episealer® surgeries ever took lace in Poland, but this is the first one since we decided to continue our expansion on the back of strong clinical performance. In addition to Poland, we have added Italy and Asia during 2020, reflecting the fact that we are executing on our strategy. We have recently appointed an individual as Head of Distribution markets, and we are continuing our global launch, at the same time as the clinical programs are running well" says Pål Ryfors, CEO Episurf Medical.
For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
 

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical's Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical's μiFidelity® system enables implants to be cost-efficiently tailored to each individual's unique injury for the optimal fit and minimal intervention. Episurf Medical's head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company's website: www.episurf.com.

https://news.cision.com/episurf/r/episealer--surgery-scheduled-in-poland,c3163257

https://mb.cision.com/Main/14691/3163257/1286604.pdf

(c) 2020 Cision. All rights reserved., source Press Releases - English